TABLE 3

Plasma pharmacokinetics (data presented as means ± S.D.) following a bolus i.v. (1 mg/kg) and p.o. (5 mg/kg) administration to Sprague Dawley rats (n = 3/group)

Intravenous parameters include total clearance (CL), volume of distribution (Vss), half-life (t1/2), and brain uptake over time (Kin). Oral parameters include maximal plasma concentration (Cmax), area under the curve (AUC), time to maximal plasma concentration (Tmax), and percentage oral availability (F).

Test articlei.v.p.o.
CLVsst1/2KinCmaxAUCinfTmaxF
ml/min/kgl/kghml/minng/mlmin*ng/mlh%
Oxycodone49.2 ± 7.11.72 ± 0.250.76 ± 0.250.12453.9 ± 45.175.6 ± 64.00.3 ± 0.14.40 ± 3.7
NKTR-18159.3 ± 8.14.19 ± 0.704.53 ± 1.100.007100.7 ± 18.4483.3 ± 97.91.8 ± 1.334.0 ± 6.9